{"entity":{"id":"beijing-tide-pharmaceutical","kind":"company","name":"Beijing Tide Pharmaceutical","aka":["Beijing Tide Pharmaceutical Co., Ltd"],"tldr":"Beijing Tide Pharmaceutical is a Chinese developer in Beijing that sponsors 2 registered cancer trials of TCC1727.","summary":"Beijing Tide Pharmaceutical appears on ClinicalTrials.gov as the industry sponsor of 2 interventional cancer trials (phase 1/2), testing TCC1727 in patients with advanced solid tumors, solid cancers, nsclc (advanced non-small cell lung cancer), gastric (stomach) cancer. OnCo records the company from the registry alone: the head office city comes from its registered name, and there are no website, funding or approval claims until they are sourced.","asOf":"2026-09-11","links":[{"label":"ClinicalTrials.gov: trials sponsored by Beijing Tide Pharmaceutical","url":"https://clinicaltrials.gov/search?spons=Beijing%20Tide%20Pharmaceutical"}],"tags":["ctgov-sponsor","china","registry-only"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct05970016","nct07371663"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"hq":"Beijing, China","country":"CN","companyType":"biotech","investors":[],"funding":[]},"route":"/companies/beijing-tide-pharmaceutical/","neighbours":{"trial":[{"id":"nct05970016","kind":"trial","name":"A Phase I/II Clinical Study in Patients with Advanced Solid Tumor.","route":"/trials/nct05970016/"},{"id":"nct07371663","kind":"trial","name":"An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors","route":"/trials/nct07371663/"}]}}